PVCT: Management Comments on Importance of Recent Patent Allowance in India
Submitted By Knobias ClipReport
Provectus Pharmaceuticals, Inc. (PVCT) recently received an allowance of its patent application in India covering its lead dermatology agent, PH-10, along with a number of related agents. The pending patent covers topical products for treatment of skin diseases such as psoriasis and eczema. Additionally, a range of active compounds are protected, each related to the active ingredient in PH-10.